ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Dec 26, 2014
HCV Competition Not New “News” for Gilead
Gilead is trading more than 40% above its 52-week low and about 20% from its 52-week high. We see no reason to panic, and the company’s trading activity more closely reflects a company whose stock price has quintupled in recent years than one that is in any trouble whatsoever. Gilead’s shares bounced right off technical support levels, and we see a long term that is still very bright for the biotech. Gilead’s shares remain underpriced even under a bear-case scenario.
Dec 19, 2014
Stocks Catapult Back To Near All-Time Highs
The markets seemingly are almost completely dependent on what the Fed does or says.
Dec 17, 2014
General Electric Is Still in Good Shape
Though shares haven’t performed as well as we thought they would to this point, we still like them, and the company’s dividend yield is solid at 3.5%.
Dec 16, 2014
Gearing Up for 2015 Outlooks
A number of industry bellwethers offered their outlooks for 2015 recently. Let’s have a look.
Dec 13, 2014
Merger Talk: Coach May Be In Play
The Dividend Growth portfolio holding may be catching the eye of a suitor.
Nov 27, 2014
Happy Thanksgiving! 5 Entrepreneurs To Be Thankful For!
Wishing all of our members the warmest holiday season!
Nov 25, 2014
Highlights from Tiffany’s Third Quarter
The luxury giant posted impressive comparable-store sales in the US, and the pace of its gross margin expansion is notable.
Nov 21, 2014
Europe and China
We’re starting to see more cracks in the global economy.
Nov 18, 2014
Medtronic Surpasses $70 Per Share
The Dividend Growth portfolio holding continues to defy gravity.
Nov 13, 2014
Look Out Below: Crude Oil Prices Continue to Tumble
We have minimal exposure to the energy sector.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.